Markers for the diagnosis of nasopharyngeal carcinoma
A marker, nasopharyngeal carcinoma technology, applied in the field of markers for nasopharyngeal carcinoma diagnosis, can solve the problems of inability to find submucosal lesions, difficulty in symmetry, false positives, etc., and achieve the effect of good diagnostic efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0022] A set of markers for the diagnosis of nasopharyngeal carcinoma, consisting of TCRBV5.4, TCRBV6.3, TCRBV6.4, TCRBV6.6, TCRBV6.7, TCRBV7.9, TCRBV8.1, TCRBV10.2, TCRBV10.3, TCRBV12 .3. TCRBV12.4, TCRBV15, TCRBV20.1, TCRBV22, TCRBV25.1.
[0023] The risk value formula of the above markers is:
[0024]TCRBV-score=(77.64385×relative expression of TCRBV5.4)-(67.4058×relative expression of TCRBV6.3)-(82.8109×relative expression of TCRBV6.4)+(5.833032×relative expression of TCRBV6.6)+(96.81641 ×TCRBV6.7 relative expression)-(1.20561×TCRBV7.9 relative expression)-(37473.7×TCRBV8.1 relative expression)-(0.02127×TCRBV10.2 relative expression)-(5.10822×TCRBV10.3 relative expression Amount)+(1.791628×TCRBV12.3 Relative Expression Amount)+(0.970634×TCRBV12.4 Relative Expression Amount)-(12.1178×TCRBV15 Relative Expression Amount)+(1.486128×TCRBV20.1 Relative Expression Amount)-(11345.1×TCRBV22 Relative Expression Amount expression level)-(24.8108×TCRBV25.1 relative expression level)...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com